ArticleJournal of thoracic disease2024

Myeloprotection effects of trilaciclib in Chinese patients with extensive stage small cell lung cancer (ES-SCLC) receiving chemotherapy-a real-world study.

Yongxing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.